Stock listing

Telix Pharmaceuticals Limited

Selected listing: T3X · MUN · EUR · DE

Telix Pharmaceuticals Limited (Munich:T3X), Health Technology. Latest release Oct 6, 2026: Telix Pharmaceuticals : First Patients Dosed with Telix’s…

T3X:MUNEURDEUpdated October 2, 2026

Ticker: Munich:T3X
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Munich
Currency: EUR

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited (TLX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Telix Pharmaceuticals Limited

Telix Pharmaceuticals : First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara (floretyrosine F 18)

October 6, 2026

First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)

October 6, 2026

Telix Pharmaceuticals : Notification of cessation of securities - TLX

October 4, 2026

Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging

September 29, 2026

FDA Fast Track for BiPASS Pre Biopsy Prostate Imaging

September 29, 2026

All Telix Pharmaceuticals Limited news →

Events

Replays

Telix Pharm Ltd (TLPPF) Q2 2026 Earnings Call
Thu, Aug 20, 2026 · 07:00 PM ET
Watch
Telix Pharm Ltd (TLPPF) Q4 2025 Earnings Call
Thu, Aug 21, 2025 · 07:30 PM ET
Watch

Research Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited company profile

View the public company page for Telix Pharmaceuticals Limited on 6ix.

Telix Pharmaceuticals Limited news

Read company news and market updates connected to Telix Pharmaceuticals Limited.

Telix Pharmaceuticals Limited investor events

Find investor webinars, events, and replay context for Telix Pharmaceuticals Limited.